200 related articles for article (PubMed ID: 6228035)
21. HLA-D and -DR antigens on human amniotic fluid cells. II. Heterogeneous expression of HLA-DR and other cell surface markers.
Kreeb G; Valentine-Thon E; Krumbacher K; Grosse-Wilde H; Passarge E
Tissue Antigens; 1984 Jan; 23(1):61-7. PubMed ID: 6367138
[TBL] [Abstract][Full Text] [Related]
22. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
Gonwa TA; Frost JP; Karr RW
J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102
[TBL] [Abstract][Full Text] [Related]
23. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR expression on cytotoxic T lymphocytes.
Ress SR; Strassmann G; Bach FH
Scand J Immunol; 1985 Nov; 22(5):455-61. PubMed ID: 2934798
[TBL] [Abstract][Full Text] [Related]
25. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
26. Stimulation by CLL cells in mixed lymphocyte culture (MLC).
Jones EH; Hockley AB; Lawler SD
Br J Cancer; 1981 Nov; 44(5):675-81. PubMed ID: 6172142
[TBL] [Abstract][Full Text] [Related]
27. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
Walsh LJ; Seymour GJ; Powell RN
J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
[TBL] [Abstract][Full Text] [Related]
28. The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes.
Whisler RL; Lindsey JA; Proctor KV; Newhouse YG; Cornwell DG
Transplantation; 1985 Jul; 40(1):57-61. PubMed ID: 3160143
[TBL] [Abstract][Full Text] [Related]
29. HLA and B-lymphocyte alloantigens in Gila River Indians.
Ensroth AF; Mann DL; Johnson AH; Knowler WC; Pettitt DJ; Bennett PH
Tissue Antigens; 1983 Mar; 21(3):198-207. PubMed ID: 6407143
[TBL] [Abstract][Full Text] [Related]
30. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
[TBL] [Abstract][Full Text] [Related]
31. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
Santoli D; Francis MK; Matera L
Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
[TBL] [Abstract][Full Text] [Related]
32. Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.
Taylor GM; Ridway JC; Fergusson WD; Harris R
Br J Cancer; 1984 Apr; 49(4):485-94. PubMed ID: 6201182
[TBL] [Abstract][Full Text] [Related]
33. HLA-A, B, C; -DR; -MT, -MB, and SB antigens on unstimulated human endothelial cells.
Neppert J; Nunez G; Stastny P
Tissue Antigens; 1984 Jul; 24(1):40-7. PubMed ID: 6592794
[TBL] [Abstract][Full Text] [Related]
34. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
[TBL] [Abstract][Full Text] [Related]
35. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes.
Fossati G; Taramelli D; Balsari A; Bogdanovich G; Andreola S; Parmiani G
Int J Cancer; 1984 May; 33(5):591-7. PubMed ID: 6233227
[TBL] [Abstract][Full Text] [Related]
36. Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture.
Suciu-Foca N; Rohowsky C; Kung P; King DW
J Exp Med; 1982 Jul; 156(1):283-8. PubMed ID: 6177823
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
38. Expression of cell surface antigens during allogeneic response studies with monoclonal antibodies to a polymorphic marker of activated lymphocytes and HLA class I and class II antigens.
Wollman EE; Kalil J
Tissue Antigens; 1983 Jul; 22(1):37-41. PubMed ID: 6225221
[TBL] [Abstract][Full Text] [Related]
39. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
40. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
